Rxo (RXO) Receivables - Other (2021 - 2025)
Historic Receivables - Other for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $26.0 million.
- Rxo's Receivables - Other rose 5294.12% to $26.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $26.0 million, marking a year-over-year increase of 5294.12%. This contributed to the annual value of $26.0 million for FY2025, which is 5294.12% up from last year.
- Per Rxo's latest filing, its Receivables - Other stood at $26.0 million for Q4 2025, which was up 5294.12% from $17.0 million recorded in Q4 2024.
- In the past 5 years, Rxo's Receivables - Other ranged from a high of $26.0 million in Q4 2025 and a low of $5.0 million during Q3 2022
- Its 5-year average for Receivables - Other is $13.8 million, with a median of $11.0 million in 2023.
- As far as peak fluctuations go, Rxo's Receivables - Other surged by 5454.55% in 2024, and later soared by 5294.12% in 2025.
- Rxo's Receivables - Other (Quarter) stood at $10.0 million in 2021, then tumbled by 50.0% to $5.0 million in 2022, then surged by 120.0% to $11.0 million in 2023, then skyrocketed by 54.55% to $17.0 million in 2024, then skyrocketed by 52.94% to $26.0 million in 2025.
- Its Receivables - Other stands at $26.0 million for Q4 2025, versus $17.0 million for Q4 2024 and $11.0 million for Q4 2023.